Osteoporosis in Biological Technology
Navigation Links
Osteoporosis in Biological Technology
... monoclonal antibody denosumab for postmenopausal osteoporosis (PMO) in Europe, Australia, New Zealand and ... to patients worldwide who are afflicted by osteoporosis and other bone loss conditions.
"Our ... benefit and value to patients with postmenopausal osteoporosis and other bone disease conditions. Together ...
... accounting for a sufficient proportion of risk of osteoporosis to develop a clinically useful DNA-based risk ... by early adulthood. Those at high risk of osteoporosis could therefore take concrete measures including ... risk Factor (PERF) study and the Australian Dubbo osteoporosis Epidemiological Study (DOES), for making this ...
... present new research findings on the genetics of osteoporosis at the 58th Annual Meeting of the American ... Fracture (SOF), multi-center study on osteoporosis and aging in women greater than or equal to age ... About Osteoporosis According to the National osteoporosis ...
... -- Results from the Global Longitudinal study of osteoporosis in Women (GLOW) showed that 55 percent of women diagnosed with osteoporosis do not believe they are at a higher risk ... potentially impact their lives." By definition, osteoporosis causes bones to become fragile and therefore more ...
... a full year's protection against the effects of osteoporosis -- a disorder that causes bones to break easily. ... patients a choice when it comes to taking their osteoporosis therapy." Reclast/Aclasta is approved in more ... is recommended that patients with postmenopausal osteoporosis take calcium and vitamin D supplements, ...
... union of the bone due to the extreme severity of the fracture or because the patient is medically impaired due to an illness such as diabetes or osteoporosis or life style choices such as smoking. These non-healing fractures, known as non-union fractures, are costly and debilitating. Aging is another ...
... blood-lead levels and lowered IQ, behavior and learning problems, increased drug abuse and crime, and adult health problems -- from dental decay and osteoporosis to cardiovascular disease, stroke, and even early cognitive deterioration associated with aging. Studies also show that infants and toddlers exposed ...
... an investigational RANK Ligand inhibitor. The indications for which Amgen is seeking FDA approval are treatment and prevention of postmenopausal osteoporosis (PMO) in women, and treatment and prevention of bone loss in patients undergoing hormone ablation for either prostate or breast cancer. The BLA ...
... peri- and postmenopausal phases, baby-boomers and seniors needing extra calcium supplementation. "The role of calcium in the pathogenesis of osteoporosis is significantly prominent. There is insufficient intake of dietary calcium and minerals in our diet, particularly in those with an active lifestyle. ...
... of specific tissue effect. "Selective estrogen modulators (SERMs) are an exciting class of drugs that are used to prevent breast cancer and osteoporosis and differ from estrogens in how they regulate gene transcription," said Dr. Dale Leitman, from the Department of Obstetrics, Gynecology and ...
... diseases with high incidence and/or mortality rates and for which there is a clear demand for more effective pharmacotherapy such as cancer, strokes, osteoporosis and infectious diseases and currently has more than 12 pipeline products. For more information about Simcere Pharmaceutical Group, please visit ...
... diseases with high incidence and/or mortality rates and for which there is a clear demand for more effective pharmacotherapy such as cancer, strokes, osteoporosis and infectious diseases and currently has more than 12 pipeline products. For more information about Simcere Pharmaceutical Group, please visit ...
... Failure -- Cystic Fibrosis -- Epilepsy -- Fibromyalgia -- Lung Cancer -- Neurodegenerative Diseases -- Novel Solid Tumor Targets -- osteoporosis -- Pre-ASH Primer "With the financial markets experiencing an unprecedented level of volatility, investment professionals place a greater premium ...
... The pipeline consists of four lead drug programs: ART621 to treat severe rheumatoid arthritis and other inflammatory diseases; ART010 to treat osteoporosis and bone cancer; ART104 to treat solid tumours in colorectal cancer; and ART150 for lung cancer and melanoma. Additionally the company has earlier ...
... with Wyeth's investigational compound bazedoxifene (BZA) alone did not appear to increase mammographic breast density in postmenopausal women with osteoporosis compared to raloxifene (the active comparator) or placebo over two years. BZA is an investigational selective estrogen receptor modulator (SERM) ...
... diseases with high incidence and/or mortality rates and for which there is a clear demand for more effective pharmacotherapy such as cancer, strokes, osteoporosis and infectious diseases and currently has more than 12 pipeline products. For more information about Simcere Pharmaceutical Group, please visit ...
... for mammography and breast biopsy, radiation treatment for early-stage breast cancer, cervical cancer screening, treatment for menorrhagia, osteoporosis assessment, preterm birth risk assessment, and mini C-arm for extremity imaging. For more information visit http://www.hologic.com . About Third ...
Amgen to Participate in Reproductive Health Drugs Advisory Committee Meeting in August
... for prevention and treatment of postmenopausal osteoporosis and prevention and treatment of bone loss in ... fracture in her remaining lifetime. Although osteoporosis treatments are available, there remains a need ... 3 pivotal studies with fracture endpoints, in the osteoporosis and prostate cancer settings, demonstrated ...FDA Accepts Amgen's Submission and Files Biologics License Application for Denosumab
... are treatment and prevention of postmenopausal osteoporosis (PMO) in women and treatment and prevention of ... Often referred to as the "silent epidemic," osteoporosis is a global problem that is increasing in ... Health Organization (WHO) has recently identified osteoporosis as a priority health issue along with other major ...... accounting for a sufficient proportion of risk of osteoporosis to develop a clinically useful DNA-based risk ... by early adulthood. Those at high risk of osteoporosis could therefore take concrete measures including ... risk Factor (PERF) study and the Australian Dubbo osteoporosis Epidemiological Study (DOES), for making this ...
... present new research findings on the genetics of osteoporosis at the 58th Annual Meeting of the American ... Fracture (SOF), multi-center study on osteoporosis and aging in women greater than or equal to age ... About Osteoporosis According to the National osteoporosis ...
Osteoporosis Drugs Increase Risk for Heart Problems
... Irregular Heartbeat Is Side Effect of Common osteoporosis Medications PHILADELPHIA, Oct. 27 /PRNewswire/ -- People who take bisphosphonates for osteoporosis may be at risk for serious atrial fibrillation ... 100 percent were women using bisphosphonates for osteoporosis with a mean age range 69 to 75 years. Patients in ...HealthYes! - Premier Provider of Mobile Preventive Medical Screenings - Launches in Alamo City
... as heart disease, stroke, arterial disease, and osteoporosis long before any symptoms are present -- ... offering the Arterial Stiffness Index. -- osteoporosis Screening -- A bone densitometer provides a ... as well as fracture risk and skeletal strength. osteoporosis is a disease in which bones become fragile and ...... -- Results from the Global Longitudinal study of osteoporosis in Women (GLOW) showed that 55 percent of women diagnosed with osteoporosis do not believe they are at a higher risk ... potentially impact their lives." By definition, osteoporosis causes bones to become fragile and therefore more ...
Global Study Reveals Differences in Standard of Care for Osteoporosis Across the World
... the Global Longitudinal Registry of osteoporosis in Women (GLOW), which will monitor the health of ... and multiple therapeutic options being available, osteoporosis remains largely under-diagnosed ... Australia. GLOW will gather information on osteoporosis risk factors, treatment approaches, patient ...Stonegate Report About Unigene Laboratories Inc.
... a sCT-based product that addresses the osteoporosis market, in 2005. Upsher-Smith Laboratories ... million range. - Safety concerns in the osteoporosis market - Bisphosphonate-based therapies, the leaders in the $7 billion osteoporosis market, have come under scrutiny following ...Interleukin Genetics Enters into New Clinical Research Collaboration with Alticor
... associated in the development of osteoporosis or cardiovascular disease - North American ... of genetic risk assessment tests in the field of osteoporosis and cardiovascular disease in new populations as ... About Osteoporosis According to the National osteoporosis ...Cooler Solutions and Leading Research Hospital to Design Revolutionary Osteoporosis Diagnosis Device
... at risk of losing bone mass during space flight. osteoporosis is a serious disease characterized by low bone ... in 3 women and 1 in 5 men over the age of 50 have osteoporosis worldwide. Working together with key ... with the potential to revolutionize the osteoporosis diagnostic area. We are working towards a day ...Radius Grants Major Pharmaceutical Company Exclusive Option to License BA058 for Osteoporosis
... all formulations of BA058, Radius' osteoporosis drug candidate. BA058 is a proprietary analog of ... of BA058 to address important unmet needs for osteoporosis patients in the near future, and in the ... in Phase II clinical trials for the treatment of osteoporosis in postmenopausal women. BA058 is designed to ...... a full year's protection against the effects of osteoporosis -- a disorder that causes bones to break easily. ... patients a choice when it comes to taking their osteoporosis therapy." Reclast/Aclasta is approved in more ... is recommended that patients with postmenopausal osteoporosis take calcium and vitamin D supplements, ...
Halozyme Therapeutics Appoints Head of Endocrinology Clinical Development
... field of endocrinology, where he has direct experience with diabetes and osteoporosis indications. Prior to joining Halozyme, Dr. Muchmore served as Medical ... insulin program, Dr. Muchmore served on the Evista Product Team for osteoporosis and breast cancer indications from 1995 to 1999 and as its Physician Group ...Zosano Pharma, Inc. Announces Appointment of Gail Schulze as Chair and CEO
... Surgery and New York Hospital, where she focused on metabolic bone and osteoporosis diseases. Stephen Worsley, vice president, business development has held ... patch formulation versus injectable Forteo in 165 women with severe osteoporosis in multiple sites across North and South America. Top line results from ...Barr Launches Generic Fosamax(R) Tablets, 70 mg
... Sodium product is indicated for the treatment and prevention of osteoporosis in postmenopausal women; for the treatment to increase bone mass in men with osteoporosis; for the treatment of glucocorticoid-induced osteoporosis in men and women receiving glucocorticoids in a daily dosage equivalent to ...Hologic Announces First Quarter Fiscal 2008 Operating Results
... a part of Cytyc) operations are now included in Breast Health, and the osteoporosis assessment, mini C-arm and MRI products are included in Skeletal Health. ... breast cancer, cervical cancer screening, treatment for menorrhagia, osteoporosis assessment, preterm birth risk assessment, and mini C-arm for extremity ...Ralf Rosskamp, M.D. Joins Biodel's Scientific Advisory Board
... contribute to the development of VIAject(TM), VIAtab(TM) and our two osteoporosis product candidates." "I am delighted to join Biodel's SAB, especially at ... tablet formulation of insulin in Phase I clinical trials and two osteoporosis product candidates in pre-clinical studies. For further information ...... union of the bone due to the extreme severity of the fracture or because the patient is medically impaired due to an illness such as diabetes or osteoporosis or life style choices such as smoking. These non-healing fractures, known as non-union fractures, are costly and debilitating. Aging is another ...
NCIIA Honors Top Collegiate Biomedical Engineering Teams
... on a biosensor to detect vitamin D levels. Although current research suggests that vitamin D deficiency can lead to health problems including osteoporosis and cancer, it is currently difficult to measure these levels accurately. The Brown team has developed a rapid method of diagnosing these with a ...Simcere Pharmaceutical Group to Announce 2009 First Quarter Earnings on Monday, May 18, 2009
... diseases with high incidence and/or mortality rates and for which there is a clear demand for more effective pharmacotherapy such as cancer, strokes, osteoporosis and infectious diseases. For more information about Simcere Pharmaceutical Group, please visit http://www.simcere.com . ...Former GE Healthcare Director, Per Foss Appointed CEO for HUNT Biosciences
... to 135,000 and reinforce the core strengths in key public health areas such as cancer, cardiovascular disease, diabetes, obstructive lung disease, osteoporosis and mental health. More than 60 % of the participants have been screened twice, 25 % have participated in all three surveys. "For both ...... blood-lead levels and lowered IQ, behavior and learning problems, increased drug abuse and crime, and adult health problems -- from dental decay and osteoporosis to cardiovascular disease, stroke, and even early cognitive deterioration associated with aging. Studies also show that infants and toddlers exposed ...
... an investigational RANK Ligand inhibitor. The indications for which Amgen is seeking FDA approval are treatment and prevention of postmenopausal osteoporosis (PMO) in women, and treatment and prevention of bone loss in patients undergoing hormone ablation for either prostate or breast cancer. The BLA ...
... peri- and postmenopausal phases, baby-boomers and seniors needing extra calcium supplementation. "The role of calcium in the pathogenesis of osteoporosis is significantly prominent. There is insufficient intake of dietary calcium and minerals in our diet, particularly in those with an active lifestyle. ...
Simcere Pharmaceutical Group Announces Preliminary Full Year Revenue and Earnings
... diseases with high incidence and/or mortality rates and for which there is a clear demand for more effective pharmacotherapy such as cancer, strokes, osteoporosis and infectious diseases and currently has more than 12 pipeline products. For more information about Simcere Pharmaceutical Group, please visit ...... of specific tissue effect. "Selective estrogen modulators (SERMs) are an exciting class of drugs that are used to prevent breast cancer and osteoporosis and differ from estrogens in how they regulate gene transcription," said Dr. Dale Leitman, from the Department of Obstetrics, Gynecology and ...
... diseases with high incidence and/or mortality rates and for which there is a clear demand for more effective pharmacotherapy such as cancer, strokes, osteoporosis and infectious diseases and currently has more than 12 pipeline products. For more information about Simcere Pharmaceutical Group, please visit ...
Amgen Positioned to Deliver Attractive Growth Over Next Five Years
... in the first half of 2009. Amgen expects to complete its Biologic License Application (BLA) data package for denosumab for post menopausal osteoporosis by the end of 2008 or early 2009. Amgen looks forward to working in due course with regulatory authorities and governments worldwide to secure ...... diseases with high incidence and/or mortality rates and for which there is a clear demand for more effective pharmacotherapy such as cancer, strokes, osteoporosis and infectious diseases and currently has more than 12 pipeline products. For more information about Simcere Pharmaceutical Group, please visit ...
... Failure -- Cystic Fibrosis -- Epilepsy -- Fibromyalgia -- Lung Cancer -- Neurodegenerative Diseases -- Novel Solid Tumor Targets -- osteoporosis -- Pre-ASH Primer "With the financial markets experiencing an unprecedented level of volatility, investment professionals place a greater premium ...
Simcere Pharmaceutical Group to Announce Third Quarter 2008 Earnings on Thursday, November 6, 2008
... diseases with high incidence and/or mortality rates and for which there is a clear demand for more effective pharmacotherapy such as cancer, strokes, osteoporosis and infectious diseases. For more information about Simcere Pharmaceutical Group, please visit http://www.simcere.com . ...... The pipeline consists of four lead drug programs: ART621 to treat severe rheumatoid arthritis and other inflammatory diseases; ART010 to treat osteoporosis and bone cancer; ART104 to treat solid tumours in colorectal cancer; and ART150 for lung cancer and melanoma. Additionally the company has earlier ...
... with Wyeth's investigational compound bazedoxifene (BZA) alone did not appear to increase mammographic breast density in postmenopausal women with osteoporosis compared to raloxifene (the active comparator) or placebo over two years. BZA is an investigational selective estrogen receptor modulator (SERM) ...
... diseases with high incidence and/or mortality rates and for which there is a clear demand for more effective pharmacotherapy such as cancer, strokes, osteoporosis and infectious diseases and currently has more than 12 pipeline products. For more information about Simcere Pharmaceutical Group, please visit ...
Hologic to Present at the Morgan Stanley Global Healthcare Unplugged Conference
... for mammography and breast biopsy, radiation treatment for early-stage breast cancer, cervical cancer screening, treatment for menorrhagia, osteoporosis assessment, preterm birth risk assessment, and mini C-arm for extremity imaging. For more information visit http://www.hologic.com . Contact: ...Renowned NJ-Based Video Assisted Thoracic Surgery (VATS) Team Completes 5,000th Successful Procedure
... Bocage, M.D., Thoracic Group, P.A. surgeon. "There are a number of co-existing or debilitating conditions such as cardiac disease, diabetes or osteoporosis that can prohibit traditional open surgery. What we want to communicate is that VATS allows thoracic surgery patients to return to their normal life ...Hologic Completes Cash Tender Offer for Third Wave Technologies, Inc.
... for mammography and breast biopsy, radiation treatment for early-stage breast cancer, cervical cancer screening, treatment for menorrhagia, osteoporosis assessment, preterm birth risk assessment, and mini C-arm for extremity imaging. For more information visit http://www.hologic.com . About Third ...... for mammography and breast biopsy, radiation treatment for early-stage breast cancer, cervical cancer screening, treatment for menorrhagia, osteoporosis assessment, preterm birth risk assessment, and mini C-arm for extremity imaging. For more information visit http://www.hologic.com . About Third ...
Other ContentscontrolcontrolcontrolcontrolcontrolcontrolcontrolcontrolcontrolcontrolnumbernumbernumbernumbernumbernumbernumbernumbernumbernumbercopycopycopycopycopycopycopycopycopycorkcorkcorollacoronarycoronarycoronarycoronarycoronarycoronarycoronaryluteumluteumluteumcorpuscorpuscorpuscorpuscorpusOther TagsProvingProvingStrikPatienPatienPatienPatienPatienbilliobilliobillio
(Date:12/11/2009)... increases, growers are being challenged to bring consistently ... bottom line, orchard owners are experimenting with new ... labor costs. , Hand thinning, a common practice ... is among the most labor-intensive of orchard practices, ... and, ultimately, prices paid by consumers. A research ...
(Date:12/11/2009)... granted an 18-month, exclusive option to startup Thermalin ... The company must reach certain milestones in order ... license on therapies designed to help patients with ... that it hopes will become an important part ... Insulin is a therapeutic protein used to manage ...
(Date:12/11/2009)... Keystone Symposia on Molecular and Cellular Biology is ... Keystone Symposia Fellows for 2010. Launched in 2008, ... scientists (postdoctoral trainees or assistant professors) to shadow ... year. Fellows are selected based on their research ... diversity in the biomedical and life sciences. As ...
Breaking Biology News(10 mins):Horizontal string trimmer reduces labor costs, increases peach size 2Case Western Reserve University grants option to startup Thermalin Diabetes Inc. 2Keystone Symposia appoints 5 Fellows as part of diversity in life science initiative 2Keystone Symposia appoints 5 Fellows as part of diversity in life science initiative 3Keystone Symposia appoints 5 Fellows as part of diversity in life science initiative 4Major health care challenges persist for D C children despite high rates of health insurance coverage RAND study finds 59154 1Major health care challenges persist for D C children despite high rates of health insurance coverage RAND study finds 59154 2Major health care challenges persist for D C children despite high rates of health insurance coverage RAND study finds 59154 3CSI in a virtual world 3A New grant furthers NC States work in forensic science 10303 1CSI in a virtual world 3A New grant furthers NC States work in forensic science 10303 2CSI in a virtual world 3A New grant furthers NC States work in forensic science 10303 3Plastic Surgery 2009 News Briefs Selected Research to be Presented on Tuesday October 27 59150 1Plastic Surgery 2009 News Briefs Selected Research to be Presented on Tuesday October 27 59150 2Plastic Surgery 2009 News Briefs Selected Research to be Presented on Tuesday October 27 59150 3(Date:12/15/2009)... that certain businesses with large areas where people gather, need ... Fire and rescue personnel agree that for any size business, ... , ... Issaquah, WA (PRWEB) December 15, ... certain businesses with large areas where people gather, need to ...
(Date:12/15/2009)... Dec. 15 "The entire San Diego Hospice ... passing of Sol Price on December 14, 2009. Mr. ... integrity, loyalty and ethics in his business, community and ... humanitarian who truly understood the responsibility of philanthropy and ... legacy will live on through his countless philanthropic efforts. ...
(Date:12/15/2009)... Southwestern Medical Center researchers have provided the most ... characteristics seen in patients with an extremely rare ... and in the December issue of the ... that patients with atypical progeroid syndrome (APS) should ... two similar but more well-defined accelerated aging disorders ...
(Date:12/14/2009)... carry oxygen, drugs, and more… , ... ... Barbara, in collaboration with scientists at University of Michigan, have ... functions of natural red blood cells, including softness, flexibility, and ... ,The primary function of natural red blood cells is to ...
(Date:12/14/2009)... PARK, Ill. and HOLLYWOOD, Fla., Dec. 14 ... ) announced today a definitive agreement to ... ), a leading provider of laboratory information ... cash. ,, The acquisition strengthens Abbott,s ... providing advanced web-based applications to help laboratories ...
Breaking Medicine News(10 mins):Health News:QuickMedical Responds to Oregon Bill Requiring Businesses to Carry Defibrillators 2Health News:QuickMedical Responds to Oregon Bill Requiring Businesses to Carry Defibrillators 3Health News:San Diego Hospice and The Institute for Palliative Medicine on the Passing of Sol Price 2Health News:Researchers ID traits of people with rare accelerated aging syndrome 2Health News:Synthetic Red Blood Cells Developed 2Health News:Synthetic Red Blood Cells Developed 3Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 2Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 3Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 4[0] QuickMedical Responds to Oregon Bill Requiring Businesses to Carry Defibrillators [1] San Diego Hospice and The Institute for Palliative Medicine on the Passing of Sol Price[0] Researchers ID traits of people with rare accelerated aging syndrome[0] Synthetic Red Blood Cells Developed [0] Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems
ReorganizeThalesCraveProvingMisappropriationArrangementsCICSEOutshinesIrrevocableSoftensStrikBruntPatienbillio
Other Tagsjail 2jail 3jail 4restrictive 2promoted 2promoted 3promoted 4promoted 5promoted 6promoted 7sperms 2theory 2theory 3theory 4theory 5theory 6theory 7theory 8theory 9theory 10doubt 2doubt 3| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |